Nevertheless, a new generation of selective MAO-B-inhibiting agents has demonstrated efficacy in alleviating PD symptoms, and these inhibitors do not cause any kind of adverse effects (Armstrong and Okun, 2020b; Alborghetti and Nicoletti, 2019). The gene discussed is MAOB; the disease is Parkinson disease.